Brief: Statera Biopharma Receives Notification Letter From Nasdaq Regarding Form 10-K Filing
22/04/2022 22:51
April 22 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA RECEIVES NOTIFICATION LETTER FROM NASDAQ
REGARDING FORM 10-K FILING
* STATERA BIOPHARMA- RECEIVED LETTER FROM NASDAQ ON APRIL
19
INDICATING CO DOES NOT COMPLY WITH CERTAIN NASDAQ LISTING RULE
FOR CONTINUED LISTING
Source text for Eikon: ID:nGNX6Qhs8P
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc